neostigmine methylsulfate

Generic: neostigmine methylsulfate

Labeler: be pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name neostigmine methylsulfate
Generic Name neostigmine methylsulfate
Labeler be pharmaceuticals inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

neostigmine methylsulfate 1 mg/mL

Manufacturer
BE Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 71839-106
Product ID 71839-106_a90a9fa9-dc93-4e87-94fa-e578918ccfce
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212512
Listing Expiration 2026-12-31
Marketing Start 2019-05-13

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71839106
Hyphenated Format 71839-106

Supplemental Identifiers

RxCUI
311935 311936
UPC
0371839106011 0371839105014
UNII
98IMH7M386

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name neostigmine methylsulfate (source: ndc)
Generic Name neostigmine methylsulfate (source: ndc)
Application Number ANDA212512 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1 VIAL, MULTI-DOSE
  • 24 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01) / 10 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (2)

71839-106-10 10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1 VIAL, MULTI-DOSE 71839-106-24 24 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01) / 10 mL in 1 VIAL, MULTI-DOSE

Ingredients (1)

neostigmine methylsulfate (1 mg/mL)

Linked Drug Pages (1)

Neostigmine methylsulfate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "a90a9fa9-dc93-4e87-94fa-e578918ccfce", "openfda": {"upc": ["0371839106011", "0371839105014"], "unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["971713db-d5ac-44c1-ada5-a56a943d79bf"], "manufacturer_name": ["BE Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "71839-106-10", "marketing_start_date": "20220317"}, {"sample": false, "description": "24 CARTON in 1 CARTON (71839-106-24)  / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "71839-106-24", "marketing_start_date": "20190513"}], "brand_name": "Neostigmine methylsulfate", "product_id": "71839-106_a90a9fa9-dc93-4e87-94fa-e578918ccfce", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "71839-106", "generic_name": "Neostigmine methylsulfate", "labeler_name": "BE Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA212512", "marketing_category": "ANDA", "marketing_start_date": "20190513", "listing_expiration_date": "20261231"}